US Bancorp’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.76K | Sell |
1,388
-1,616
| -54% | -$5.54K | ﹤0.01% | 3647 |
|
|
2025
Q1 | $6.7K | Buy |
3,004
+1,048
| +54% | +$2.34K | ﹤0.01% | 3555 |
|
|
2024
Q4 | $5.73K | Buy |
1,956
+460
| +31% | +$1.35K | ﹤0.01% | 3604 |
|
|
2024
Q3 | $3.89K | Sell |
1,496
-100
| -6% | -$260 | ﹤0.01% | 3639 |
|
|
2024
Q2 | $4.72K | Sell |
1,596
-1,359
| -46% | -$4.02K | ﹤0.01% | 3516 |
|
|
2024
Q1 | $13.4K | Hold |
2,955
| – | – | ﹤0.01% | 3223 |
|
|
2023
Q4 | $16.9K | Buy |
2,955
+721
| +32% | +$4.12K | ﹤0.01% | 3124 |
|
|
2023
Q3 | $10.3K | Buy |
2,234
+18
| +0.8% | +$83 | ﹤0.01% | 3158 |
|
|
2023
Q2 | $14.3K | Buy |
2,216
+1,060
| +92% | +$6.85K | ﹤0.01% | 3100 |
|
|
2023
Q1 | $8.72K | Sell |
1,156
-274
| -19% | -$2.07K | ﹤0.01% | 3320 |
|
|
2022
Q4 | $14.5K | Buy |
1,430
+1,360
| +1,943% | +$13.8K | ﹤0.01% | 3153 |
|
|
2022
Q3 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 3877 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$11K | – | 4012 |
|
|
2021
Q2 | $11K | Buy |
500
+416
| +495% | +$9.15K | ﹤0.01% | 3337 |
|
|
2021
Q1 | $3K | Buy |
+84
| New | +$3K | ﹤0.01% | 3561 |
|